Pfizer gets USFDA approval for Fragmin to treat blood clot in pediatric patients Farhat Nasim19 May 2019 9:45 AM ISTThe efficacy of Fragmin in children was based on a single trial with 38 pediatric patients with symptomatic deep vein thrombosis and/or pulmonary...
FDA approves new blood cancer treatment from Pfizer Medical Dialogues Bureau22 Nov 2018 9:15 AM ISTThe U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a...
FDA expands approval for Pfizer cancer drug Studnt Ruby Khatun Khatun20 Nov 2017 10:07 AM ISTThe U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of...
